Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency-Reference-Cited by-同舟云学术

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency

Published:2017-05-10 Issue:39 Volume:8 Page:65090-65099
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Dosch Joseph¹,Ziemke Elizabeth¹,Wan Shanshan²,Luker Kathryn¹,Welling Theodore²,Hardiman Karin²,Fearon Eric³,Thomas Suneetha⁴,Flynn Matthew⁴,Rios-Doria Jonathan⁴,Hollingsworth Robert⁴,Herbst Ronald⁴,Hurt Elaine⁴,Sebolt-Leopold Judith¹

Affiliation:

1. Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA

2. Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA

3. Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA

4. Department of Oncology Research, MedImmune, LLC, Gaithersburg, MD 20878, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between TEX14 and ADAM17 expressions in colorectal cancer tissues of elderly patients and neoplasm staging, invasion, and metastasis;World Journal of Clinical Cases;2024-08-26

2. Targeting of the NOX1/ADAM17 Enzymatic Complex Regulates Soluble MCAM-Dependent Pro-Tumorigenic Activity in Colorectal Cancer;Biomedicines;2023-11-30

3. Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity;Frontiers in Cell and Developmental Biology;2023-10-04

4. The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond;The FEBS Journal;2023-08-11

5. Targeting Oncogenic Wnt/β-Catenin Signaling in Adrenocortical Carcinoma Disrupts ECM Expression and Impairs Tumor Growth;Cancers;2023-07-10